Kajian Potensi Interaksi Obat pada Pasien Gagal Ginjal Rawat Jalan RS “X” Kota Cirebon

Nur Rahmi Hidayati(1*), Rinto Susilo(2), Mila Anggraeni(3)

(1) STF Muhammadiyah Cirebon
(2) 
(3) 
(*) Corresponding Author

Abstract

Drug interactions are one of part of Drug Related Problem (DRP) which significantly affect the development patient health. This study aims to determine the characteristics of kidney failure patients (age and genitals), an overview of the number of potential drug interactions, an overview of the types and amounts of other drugs interacting, and the severity of drug interactions in kidney failure patients in the Outpatient of “X” Hospital Cirebon City. This study involves 126 patient prescriptions. This type of research is a non-experimental research with descriptive analysis method, and using data collection methods with prospective random sampling technique in the Outpatient of RS “X” Cirebon. The results of the research from 126 samples obtained showed that the characteristics of Kidney Failure patients were predominantly male as many as 64 people (50.79%), the most age was in the age range 61-70 years as many as 38 people (30.16%). drug interactions 78 sheets of prescriptions (61.9%), the most severity of drug interactions was the strict / significant monitoring of 128 events (64.65%), the average of drug interactions per prescription sheet was 3 interactions, the type and number of the most interacting drug was furosemide + folic acid with 32 potential interactions (41.02%).

Keywords

Kidney Failure, Drug Interaction, outpatient

Full Text:

PDF

References

Adibe, M.O., Ewelum, P.C., Amorha, K.C., 2017. Evaluation of drug-drug interactions among patients with chronic kidney disease in a South-Eastern Nigeria tertiary hospital: a retrospective study. The Pan African Medical Journal, 28: 199.

Aslam, M., Tan, C.K., Prayitno, A., 2003. Farmasi klinis: menuju pengobatan rasional dan penghargaan pilihan pasien. Jakarta: PT. Elex Media Komputindo. Hal. 18-19, 137-141.

Bailie, G.R. Johnson, C.A., Mason, N.A., Peter, W.L.St., 2004. Medfacts pocket guide of drug interaction. Second Edition. Bone Care International, Nephrology Pharmacy Associated, Inc : Middleton

Busari, A. A., Oreagba, I. A., Oshikoya, K.A. Kayode, M. O., Olayemi, S. O., 2019. High risk of drug–drug interactions among hospitalized patients with kidney diseases at a nigerian teaching hospital: A Call for action. Nigerian Medical Journal, Nov-Dec; 60(6): 317–25.

Bushra R., Nousheen A., Arshad Y. K.. 2011. Food-drug interactions. Oman Medical Journal.

Cahyaningsih, D., Niken., 2011. Hemodialisis (cuci darah), Yogyakarta: Mitra Cendikia.

Dalimunthe, A., 2009. Interaksi obat pada anti mikroba, Departemen Farmakologi, Fakultas Farmasi, Universitas Sumatra Utara, Medan.

Diaz, G. S., Pico, A.M.P., Santisteban, M.A.S., Bernalt, V.G., Mayordomo, R., Dorado, P., 2020. Prevalence of potential drug–drug interaction risk among chronic kidney disease patients in a spanish hospital. Pharmaceutics. 2020 Aug; 12(8): 713.

Drugs.com, (2016). Drug interaction checker. https://www.drugs.com/drug_interactions.html

Fatimah, S., 2019, Studi potensi interaksi obat pada terapi pasien penyakit ginjal kronis (PGK) di instalasi rawat inap RSUD Jombang tahun 2016. Tesis. UIN Malang.

Gitawati, R., 2008. Interaksi obat dan beberapa implikasinya. Media Litbang Kesehatan, Volume XVIII Nomor 4. P: (175-184), http://ejournal.litbang.kemkes.go.id/index.php/MPK/article/view/1086

Indonesian Renal Registry (IRR), 2013. Report of Indonesia Renal Registry (2012). Perhimpunan Nefrologi Indonesia (PERNEFRI) 5th Edition.

Kementerian Kesehatan RI, 2013. Riset Kesehatan Dasar (RISKESDAS) 2013, Jakarta.

Kenward, R., dan Tan, C.K, 2003. Penggunaan obat pada gangguan ginjal, dalam Aslam Farmasi Klinis: Menuju Pengobatan Rasional dan Penghargaan Pilihan Pasien 2003, 140-153, PT. Elex Media Komputindo Gramedia, Jakarta.

Kono, B.R., 2019. Analisis drp interaksi obat pasien penyakit ginjal kronik di instalasi rawat inap RSUD Profesor Dr. W.Z. Johannes Kupang. Tesis. Universitas Citra Bangsa.

Maifitrianti, 2016. Identifikasi interaksi obat-obat potensial pada pasien gagal ginjal kronik RSPAD Gatot Soebroto. Farmasains, Vol. 3, No.2: 59-63.

Mariam, S. 2016. Evaluasi kejadian interaksi obat pada pasien rawat inap geriatri penderita gagal jantung. Skripsi. Sekolah Tinggi Ilmu Farmasi dan Industri, Bogor.

Medscape, 2019. Medscape Reference, Aplikasi Medscape. [Akses 2020]

National Kidney Foundation, 2016. About Chronic Kidney Disease; 2016 [dikutip 29 Jan 2017] : https://www.kidney.org/kidneydisease/aboutckd

Norton, J.M., Moxey-Mims, M.M., Eggers, P.W., Narva, A.S., Star, R.A., Kimmel, P.L., and Rodgers, G.P., 2016. Social determinants of racial disparities in CKD. JASN, September 2016, 27 (9) 2576-95, DOI: https://doi.org/10.1681/ASN.2016010027

Pasangka, I.T., Tjitrosantoso, H., Lolo, W.A., 2017. Identifikasi potensi interaksi obat pada pasien gagal ginjal, Jurnal Ilmiah Farmasi, Vol. 6 No. 4. https://ejournal.unsrat.ac.id/index.php/pharmacon/article/view/17727/17252.

Prasetya, A.A.N.P.R., Karsana, A.A.R., dan Swastini., D.A., 2012. Kajian interaksi obat pada pengobatan pasien gagal ginjal kronis hipertensi, Jurnal Farmasi Udayana, Desember 2012: p9-15.

Rahardjo, P., 2006. Hemodialisis dalam ilmu penyakit dalam. Jakarta: Penerbit FKUI: Jilid 1, hal 579.

Rama, M., Viswanathan, G., Acharya,D., Attur, PR., Reddy, N P., Raghavan,VS., 2012. Assessment of drug-drug interaction among renal failure patients of nephrology ward in a South Indian tertiary care hospital. Indian journal of pharmaceutical Sciences. 74(1): 63–68

Stamatakis, M.K., 2008. Acute renal failure. In M. A. C. Burns., Wells, B. G., Schwinghammer, T. L., Malone, P.M., Kolesar, J.M. & J. T. Dipiro., eds. Pharmacotherapy Principles and Practice. New York: The McGraw-Hill Companies, p. 361-370.

Supadmi, W., Jumiati, 2017. Interaksi obat pada pasien gagal ginjal kronik di bangsal hemodialisis Rumah Sakit Happyland Yogyakarta. Akfarindo, Vol. 2 No. 2 2017: 24-31.

Wilson, L. M. 2005. Gagal Ginjal Kronik. Dalam: Wilson, L.M., Price, S.A., Penyunting. Patofisiologi: konsep klinis proses-proses penyakit edisi ke-6. Jakarta: ECG, hal. 912-47.

DOI: 10.23917/pharmacon.v17i2.12948

Article Metrics

Abstract view(s): 1594 time(s)
PDF: 2348 time(s)

Refbacks

  • There are currently no refbacks.